Home LiteratureArticle Details
PMID: 19870847 Published · ppublish English Journal Article

QUANTITATIVE RELATIONSHIPS BETWEEN THE IMMUNIZING DOSE OF EPIDEMIC INFLUENZA VIRUS AND THE RESULTANT IMMUNITY.

The Journal of experimental medicine ·Vol. 69 ·No. 2 ·1939-01-31 ·Pages 283-300

Francis T

Abstract

A direct proportion exists between the concentration of epidemic influenza virus used for intraperitoneal immunization of mice and the degree of immunity to intranasal infection which develops. Mice vaccinated with virus of a given strength resist infection with virus of the same concentration but not more. An irreducible minimum exists since mice vaccinated with less than ten intranasal lethal doses do not develop sufficient immunity to overcome intranasal infection with virus of the same strength. The fact that there exists a limiting threshold for the degree of immunity which a certain strength of virus will induce indicates that the virus does not multiply after intraperitoneal inoculations. In ferrets a state of partial immunity is induced as a result of subcutaneous vaccination with active influenza virus. Vaccination with doses containing 100 or more intranasal infectious units is required for the production of circulating antibodies, protection of the animals from pulmonary involvement, and modification of the severity of the disease. On the other hand, intranasal inoculation with one infectious unit results in a firm, immediate immunity, although the duration of immunity may bear a relation to the severity of the original infection and consequently to the size of the infecting dose. Ferrets in a state of partial immunity resulting from subcutaneous vaccination, or from the waning of a firm immunity following infection, respond to intranasal inoculation of influenza virus with an accelerated production of neutralizing antibodies. The antibody titer under these conditions reaches a much higher level than occurs following a primary infection. Fully immune animals, however, show no further antibody response to a second inoculation.

Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Francis T
Laboratories of the International Health Division of The Rockefeller Foundation, New York.
References (9)
9 references, click to expand
  1. THE ANTIBODY RESPONSE OF HUMAN SUBJECTS VACCINATED WITH THE VIRUS OF HUMAN INFLUENZA.
    J Exp Med. 1937 Jan 31;65(2):251-9 PMID: 19870599
  2. Etiological and Serological Studies in Epidemic Influenza.
    Am J Public Health Nations Health. 1937 Nov;27(11):1141-60 PMID: 18014734
  3. IMMUNIZATION EXPERIMENTS WITH SWINE INFLUENZA VIRUS.
    J Exp Med. 1936 Jun 30;64(1):47-61 PMID: 19870522
  4. RESULTS OF IMMUNIZATION BY MEANS OF ACTIVE VIRUS OF HUMAN INFLUENZA.
    J Clin Invest. 1937 Mar;16(2):237-43 PMID: 16694474
  5. TRANSMISSION OF INFLUENZA BY A FILTERABLE VIRUS.
    Science. 1934 Nov 16;80(2081):457-9 PMID: 17795179
  6. ACTIVE IMMUNIZATION OF GUINEA PIGS WITH THE VIRUS OF EQUINE ENCEPHALOMYELITIS : III. QUANTITATIVE STUDIES OF SERUM ANTIVIRAL BODIES IN ANIMALS IMMUNIZED WITH ACTIVE AND INACTIVE VIRUS.
    J Exp Med. 1936 Jul 31;64(2):217-22 PMID: 19870531
  7. ACTIVE IMMUNIZATION OF GUINEA PIGS WITH THE VIRUS OF EQUINE ENCEPHALOMYELITIS : II. IMMUNIZATION WITH FORMOLIZED VIRUS.
    J Exp Med. 1936 Apr 30;63(5):745-65 PMID: 19870501
  8. THE DEMONSTRATION OF LESIONS AND VIRUS IN THE LUNGS OF MICE RECEIVING LARGE INTRA-PERITONEAL INOCULATIONS OF EPIDEMIC INFLUENZA VIRUS.
    J Exp Med. 1938 May 31;67(6):953-72 PMID: 19870768
  9. ACTIVE IMMUNICATION OF GUINEA PIGS WITH THE VIRUS OF EQUINE ENCEPHALOMYELITIS : I. QUANTITATIVE EXPERIMENTS WITH VARIOUS PREPARATIONS OF ACTIVE VIRUS.
    J Exp Med. 1936 Feb 29;63(3):311-24 PMID: 19870474
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1939-01-31
Pages
283-300
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2133739
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com